The project consists of three components: a research facility, an animal welfare facility, and a bioreactor facility. In cooperation with academic, industrial, governmental, and non-governmental institutions, Center staff will use these new facilities to conduct basic and preclinical studies as well as clinical trials with stem cells. Ultimately, the project will leverage the therapeutic potential of stem cells to develop cellular therapies, tissues, and organs to advance regenerative medicine and promote health and welfare in
“This project represents a great step for the country,” adds Hill Chief Executive Officer
About
Forward Looking Statements
Certain statements contained herein may be considered “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, and it is our intent that any such statements be protected by the safe harbor created thereby. Except for historical information, the matters set forth herein including, but not limited to, any statements of belief or intent, any statements concerning our plans, strategies, and objectives for future operations are forward-looking statements. These forward-looking statements are based on our current expectations, estimates and assumptions and are subject to certain risks and uncertainties. Although we believe that the expectations, estimates, and assumptions reflected in our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of our forward-looking statements. Important factors that could cause our actual results to differ materially from estimates or projections contained in our forward-looking statements are set forth in the Risk Factors section and elsewhere in the reports we have filed with the
Senior Vice President
(215) 309-7707
[email protected]
(212) 836-9608
[email protected]
Source:
2022 GlobeNewswire, Inc., source